Assessment Of COPD Severity In A Real-Life Cohort Of German Patients-1-Year Follow-Up Data From The Daccord Study

被引：0
|
作者：
Worth, H. [1 ]
Buhl, R. [2 ]
Criee, C. -P. [3 ]
Kardos, P. [4 ,5 ]
Lossi, N. [6 ]
Mailaender, C. [6 ]
Vogelmeier, C. [7 ]
机构：
[1] Facharztforum Fuerth, Furth, Germany
[2] Univ Hosp Mainz, Mainz, Germany
[3] Evangel Hosp Goettingen Weende, Bovenden, Germany
[4] Grp Practice, Frankfurt, Germany
[5] Ctr Allergy Resp & Sleep Med, Frankfurt, Germany
[6] Novartis Pharma GmbH, Nurnberg, Germany
[7] Univ Marburg, Marburg, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1706
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study
    Monteleone, Palmiero
    Cascino, Giammarco
    Rossi, Alessandro
    Rocca, Paola
    Bertolino, Alessandro
    Aguglia, Eugenio
    Amore, Mario
    Andriola, Ileana
    Bellomo, Antonello
    Biondi, Massimo
    Brasso, Claudio
    Carpiniello, Bernardo
    Collantoni, Enrico
    Dell'Osso, Liliana
    di Giannantonio, Massimo
    Fabrazzo, Michele
    Fagiolini, Andrea
    Giordano, Giulia Maria
    Marcatili, Matteo
    Marchesi, Carlo
    Monteleone, Alessio Maria
    Pompili, Maurizio
    Roncone, Rita
    Siracusano, Alberto
    Vita, Antonio
    Zeppegno, Patrizia
    Galderisi, Silvana
    Maj, Mario
    Italian Network Res Psychoses
    SCHIZOPHRENIA RESEARCH, 2022, 248 : 279 - 286
  • [42] Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort
    Hentgen, Veronique
    Kone-Paut, Isabelle
    Belot, Alexandre
    Galeotti, Caroline
    Grateau, Gilles
    Carbasse, Aurelia
    Pagnier, Anne
    Pillet, Pascal
    Delord, Marc
    Hofer, Michael
    Georgin-Lavialle, Sophie
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [43] Classifying Patients as GOLD A-D According to GOLD 2017 Recommendations: An Analysis of the German Real-Life DACCORD Study
    Worth, H.
    Buhl, R.
    Criee, C. P.
    Kardos, P.
    Lossi, N.
    Vogelmeier, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [44] Disease Progression in COPD Patients Classified as Gold D According to Gold 2011 or Gold 2017 in the Real-Life Daccord Study
    Worth, H.
    Kardos, P.
    Criee, C.
    Berschneider, K.
    Obermoser, V.
    Vogelmeier, C.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [45] Follow-up of a cohort of patients with noncystic fibrosis bronchiectasis for 1 year
    Mateus, Simone Paulo
    Salles, Raquel Esteves Brandao
    Costa, Walter
    da Costa, Claudia Henrique
    Lopes, Agnaldo Jose
    Tura, Bernardo Rangel
    Rufino, Rogerio
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (03): : 329 - 336
  • [46] Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study
    Saes, Joline L.
    Verhagen, Marieke J. A.
    Meijer, Karina
    Cnossen, Marjon H.
    Schutgens, Roger E. G.
    Peters, Marjolein
    Nieuwenhuizen, Laurens
    van der Meer, Felix J. M.
    Kruis, Ilmar C.
    van Heerde, Waander L.
    Schols, Saskia E. M.
    BLOOD ADVANCES, 2020, 4 (20) : 5025 - 5034
  • [47] Characterisation of healthcare utilisation and cost of haemophilia care in real-life: A 4-year follow-up study in Finland
    Ventola, Hanna
    Vesikansa, Aino
    Jokelainen, Jari
    Siitonen, Timo
    Ettala, Pia
    Laine, Outi
    Lehtinen, Elina
    Lepantalo, Aino
    Patronen, Maria
    Partanen, Anu
    Linna, Miika
    Ylisaukko-oja, Tero
    Lassila, Riitta
    HAEMOPHILIA, 2021, 27 (01) : E30 - E39
  • [48] Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry
    Kvamme, Maria K.
    Lie, Elisabeth
    Kvien, Tore K.
    Kristiansen, Ivar S.
    RHEUMATOLOGY, 2012, 51 (09) : 1618 - 1627
  • [49] Soluble Guanylate Cyclase Stimulators (Riociguat) in Pulmonary Hypertension: Data from Real-Life Clinical Practice in a 3-Year Follow-Up
    Spilimbergo, Fernanda Brum
    Assmann, Tais Silveira
    Bellon, Marcelo
    Hoscheidt, Lais Machado
    Braz Caurio, Cassia Ferreira
    Puchalski, Marcia
    Hochhegger, Bruno
    Roncato, Gabriela
    Bohns Meyer, Gisela Martina
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2022, 118 (06) : 1059 - 1066
  • [50] Costs of chronic bronchitis and COPD - A 1-year follow-up study
    Miravitlles, M
    Murio, C
    Guerrero, T
    Gisbert, R
    CHEST, 2003, 123 (03) : 784 - 791
12345